April 25, 2019

Last week, two cannabis giants struck a $3.4-billion deal: Canadian producer Canopy Growth announced that it has purchased the rights to acquire U.S.-based multi-state cannabis operator Acreage Holdings, contingent upon the potential U.S. federal legalization of cannabis. This billion-dollar international MA deal is on pace with what Adnant Consulting CEO Sabas Carrillo calls the year […]

by

Valens GroWorks Corporation (CSE:VGW) announced Thursday that it has signed a multi-year extraction services agreement to provide cannabis and hemp extraction services to HEXO Corp.(TSX:HEXO) (NYSEAMERICAN:HEXO), a leading cannabis producer and consumer goods cannabis company. The agreement has an initial two-year term from the date of the first shipment, with HEXO supplying Valens with an […]

by

BOCA RATON, Fla., April 25, 2019 /PRNewswire/ — Bad Ass Cannabis Products introduced its CBD oil elixirs to major retailers at this month’s Weight Management, Sports Nutrition, Vitamin Hemp Solutions EPPS conference in Orlando. During the four-day conference, company representatives met in private one-on-one meetings with leading buyers from some of the nation’s top retailers, […]

by

Controlling dosage can be a challenge when cooking with CBD or THC, especially for home chefs like Christine Manente, a Connecticut resident who holds a state-issued medical marijuana card and used cannabis to blunt the pain from a work-related injury. “I have a brownie pan that splits into 18 equal size pieces,” she told Healthline. […]

by

Dr. Stephanie McGrath is overseeing clinical trials using CBD to treat dogs with epilepsy and osteoarthritis. Photo: John Eisele/CSU Photography Dr. Stephanie McGrath, a neurologist at Colorado State University’s James L. Voss Veterinary Teaching Hospital, has revealed initial findings from a groundbreaking study to assess the use of cannabidiol, or CBD, for dogs with epilepsy. Based on […]

by

The stock of Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) registered an increase of 30.83% in short interest. ZYNE’s total short interest was 3.01 million shares in April as published by FINRA. Its up 30.83% from 2.30 million shares, reported previously. With 1.42M shares average volume, it will take short sellers 2 days to cover their ZYNE’s short […]

by

“These data provide additional evidence supporting the notion that opioid-cannabinoid mixtures that are effective for treating pain do not have greater, and in some cases have less, adverse effects compared with larger doses of each drug alone,” said Vanessa Minervini, PhD, a postdoctoral fellow at the University of Texas Health Science Center at San Antonio. […]

by

A new study has found that certain people may be genetically prone to cannabis use disorder (or cannabis “addiction,” per the language of the study). The study, led by Dr. Chandni Hindocha of the University College London (UCL) Clinical Psychopharmacology Unit and published in Addiction Biology, investigated three genetic markers of a genetic variation. While […]

by

Wikimedia Commons/Basile Morin Heh. A new study by University of Colorado researchers has debunked the stereotype of the lazy stoner. The researchers surveyed more than 600 marijuana users in states where pot is legal. They found that nearly five out of six participants reported using marijuana one hour before or up to four hours after […]

by

Many individuals with cancer turn to medical marijuana for symptom relief, with rates of use in the United States increasing over time, according to a new study published in CANCER. However, more studies are needed to assess its efficacy in treating cancer-related pain in order to further support marijuana use as an alternative to opioid […]

by

A study recently published in Lancet Psychiatry suggest that regular cannabis consumers may be risking their mental health. According to the study, there’s a connection between regular cannabis use and the development of psychosis. In addition to the frequency of cannabis use, the researchers noticed that the incidence of psychosis correlated positively with more potent […]

by